If the FDA approves use of zuranolone, the first fast-acting oral medication for postpartum depression and major depressive disorder, the drug will become part of Cleveland Clinic’s s robust toolkit for caring for patients with those conditions.
Suicidal Thoughts Not Uncommon in MS, Epilepsy Patients
Patients with epilepsy and multiple sclerosis have high rates of depression and an increased risk for suicide. Cleveland Clinic analysis shows the PHQ-9 can be useful in identifying who may benefit from psychiatric care.